Overview

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
Randomized pilot trial comparing scheduled morphine dosing with a weaning protocol to intermittent morphine dosing on an as-needed basis for newborns with neonatal abstinence syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University
Treatments:
Morphine